Impalpable Breast Cancer and Service Delivery During the COVID-19 Pandemic – the Role of Radiofrequency Tag localization

Main Article Content

Jonathan Strickland
Beatrix Elsberger
Gerald Lip
Mairi Fuller
Yazan Masannat

Keywords

Breast Cancer, Breast Surgery, Radiofrequency, Covid-19

Abstract

Background: Radiofrequency tags are used to localize breast lesions for surgery. During the Covid-19 pandemic, these offered the flexibility of inserting the Tags days or weeks before surgery. This made logistics of planning theatres lists easier, especially with most of the lists having been moved off site.
Methods: In the 7 weeks following the first lockdown in the UK, we reviewed all planned admissions for breast surgery looking at the types of surgery offered, type of localization used and assessed which cases would not have been able to go ahead had radiofrequency tags not been available.
Results: Out of 85 planned admission, 83 had surgery, 11 were for re-excision of margins and 72 for their first breast surgery excision (mastectomy or breast conservation). Out of the 54 that had breast conserving surgery, 40 needed localization, out of whom 27 had radiofrequency tags. Looking at theatre order list and location of surgery, 20 out of the 27 would not have had their surgery had radiofrequency tags not been available, which is 50% of the patients needing localization.
Conclusion: Radiofrequency tags are new devices used for breast lesion localization that offer a much-needed flexibility especially as seen during the Covid-19 pandemic.

References

1. The UK National Institute of Health and Care Excellence. COVID-19 rapid guideline: delivery of systemic anticancer treatments. 2020.
2. Association of Breast Surgery Statement re Covid [press release]. 27th of April 2020.
3. Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020;181, 487–497.
4. Frank HA, Hall FM, Steer ML. Preoperative localization of nonpalpable breast lesions demonstrated by mammography. N Engl J Med. 1976;295(5):259-60.
5. Milligan R, Pieri A, Critchley A, Peace R, Lennard T, et al. Radioactive seed localization compared with wire-guided localization of non-palpable breast carcinoma in breast conservation surgery- the first experience in the United Kingdom. Br J Radiol. 2018;91(1081):20170268.
6. Zacharioudakis K, Down S, Bholah Z, Lee S, Khan T, et al. Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study. Eur J Surg Oncol. 2019;45(11):2016-21.
7. McGugin C, Spivey T, Coopey S, Smith B, Kelly B, et al. Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions. Breast Cancer Res Treat. 2019;177(3):735-9.
8. Wazir U, Tayeh S, Perry N, Michell M, Malhotra A, et al. Wireless Breast Localization Using Radio-frequency Identification Tags: The First Reported European Experience in Breast Cancer. In Vivo. 2020;34(1):233-8.
9. Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020;25(6):e936-45.

Article Statistics :Views : 138 | Downloads : 115 : 10